Add to ORKGA meta-analysis based on Individual Patient data went to demonstrate the significant main effect of acamprosate in enhancing patient abstinence after detofixation. A general linear Model also highlighted the importance of baseline motivatin (p<.001) and non significant interaction country-treatment effect
1. Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBIN...
Naturalistic randomised study controlled against any other treatment to assess the effect of acampro...
Objective. To examine whether the addition of acamprosate to Cognitive Behavioural Therapy (CBT) out...
We describe Efficacy and Safety of acamprosate in enhancing abstinence on detoxified patients, a met...
An assessment of the efficacy of treatment with acamprosate was, therefore, undertaken using meta-an...
Acamprosate was shown to help to maintain abstinence on alcoholic patients. In this paper, we show t...
Acamprosate is an FDA-approved medication that enhances abstinence in alcohol-dependent patients. A ...
Impact of active follow-up on abstinence in alcohol-dependent patients treated with acamprosate. Res...
Method: Randomized parallel groups prospective trial to assess the efficacy of nursing follow up of...
In this review, acamprosate effect in reducing consumption was assessed with an IPD meta-analysi
We compared effects of the standard 2 g dose (n=258) and an exploratory 3 g dose of acamprosate (n=8...
Meta-analysis based on an international open label prospective study has shown that abstinence durin...
Initial severity of the patient before clinical trial is considered as the main predictor of therapy...
Data on patients' alcohol consumption from 15 placebo-controlled treatment studies (n = 3309) were e...
Acamprosate is an FDA-approved medication that enhances abstinence in alcohol-dependent patients. A ...
1. Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBIN...
Naturalistic randomised study controlled against any other treatment to assess the effect of acampro...
Objective. To examine whether the addition of acamprosate to Cognitive Behavioural Therapy (CBT) out...
We describe Efficacy and Safety of acamprosate in enhancing abstinence on detoxified patients, a met...
An assessment of the efficacy of treatment with acamprosate was, therefore, undertaken using meta-an...
Acamprosate was shown to help to maintain abstinence on alcoholic patients. In this paper, we show t...
Acamprosate is an FDA-approved medication that enhances abstinence in alcohol-dependent patients. A ...
Impact of active follow-up on abstinence in alcohol-dependent patients treated with acamprosate. Res...
Method: Randomized parallel groups prospective trial to assess the efficacy of nursing follow up of...
In this review, acamprosate effect in reducing consumption was assessed with an IPD meta-analysi
We compared effects of the standard 2 g dose (n=258) and an exploratory 3 g dose of acamprosate (n=8...
Meta-analysis based on an international open label prospective study has shown that abstinence durin...
Initial severity of the patient before clinical trial is considered as the main predictor of therapy...
Data on patients' alcohol consumption from 15 placebo-controlled treatment studies (n = 3309) were e...
Acamprosate is an FDA-approved medication that enhances abstinence in alcohol-dependent patients. A ...
1. Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBIN...
Naturalistic randomised study controlled against any other treatment to assess the effect of acampro...
Objective. To examine whether the addition of acamprosate to Cognitive Behavioural Therapy (CBT) out...